Outlook Therapeutics appoints Surendra Sharma as SVP, medical affairs

Outlook Therapeutics announced the appointments of Surendra Sharma, MD, as Senior Vice President, Medical Affairs, and Glen Olsheim as Executive Director, Commercial Excellence. Most recently, Sharma was Senior Medical Director, Cornea, Dry Eye and Retina, Global Medical Affairs at Santen Pharmaceuticals. Prior to joining Outlook Therapeutics, in his role as the VP of Business and New Product Development at Fagron Sterile Services,Olsheim focused on driving revenue, profit and value in repackaging IV bevacizumab for ophthalmic use in retina indications.